- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07687082
Prevalence and Risk Factors for Chronic Post-Surgical Pain Following Video-Assisted Thoracic Surgery : The EVATHO Prospective Bicentric Cohort Study. (EVATHO)
Study of the Prevalence of Chronic Postoperative Pain After Video-Assisted Thoracic Surgery: A Bicentric Cohort Study
Chronic post-surgical pain (CPSP) remains a common complication after thoracic surgery and may significantly impair patients' quality of life. Although the widespread adoption of video-assisted thoracic surgery (VATS) has reduced surgical trauma and improved postoperative recovery, a substantial proportion of patients still develop persistent pain.
The EVATHO study is a multicenter prospective observational cohort designed to determine the prevalence of CPSP three months after VATS and to identify perioperative factors associated with its development. Adult patients undergoing thoracic surgery by VATS at Montpellier and Nice University Hospitals will be prospectively enrolled.
Pain intensity, neuropathic pain characteristics, anxiety, depression, quality of life, and analgesic consumption will be assessed using validated questionnaires during the perioperative period and at 1 and 3 months after surgery. The results of this study may help identify patients at increased risk of CPSP and improve perioperative pain management strategies following thoracic surgery.
Aperçu de l'étude
Statut
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Benjamin Bourdois, MD
- Numéro de téléphone: +33467335958
- E-mail: b-bourdois@chu-montpellier.fr
Sauvegarde des contacts de l'étude
- Nom: Sophie Bringuier, MD
- Numéro de téléphone: +33467335958
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Adult patients undergoing video-assisted thoracic surgery (VATS) for thoracic surgery
Exclusion Criteria:
- Age <18 years
- Adults under legal protection or unable to provide informed non-opposition
- Patients unable to understand or complete the study questionnaires
- Patients not affiliated with a French health insurance scheme.
- Adults under legal protection, including judicial safeguard, guardianship, or curatorship.
- Participation in another clinical study involving an ongoing exclusion period.
- Pregnant or breastfeeding women.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of participants with chronic post-surgical pain
Délai: 3 months after surgery.
|
Chronic post-surgical pain defined as a Brief Pain Inventory (BPI) average pain score greater than 3 at the 3-month postoperative follow-up.
|
3 months after surgery.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postoperative pain at 1 month after VATS
Délai: 1 month after thoracic surgery
|
Post-surgical pain defined as a Brief Pain Inventory (BPI) average pain score greater than 3 at the 1-month postoperative follow-up.
|
1 month after thoracic surgery
|
|
Visual Analogue Scale (VAS) pain score
Délai: Preoperative assessment, postoperative day 1, postoperative day 2, 1 month, and 3 months after surgery.
|
Pain intensity measured using the Visual Analogue Scale (VAS), with scores ranging from 0 (no pain) to 10 (worst imaginable pain).
|
Preoperative assessment, postoperative day 1, postoperative day 2, 1 month, and 3 months after surgery.
|
|
Cumulative postoperative opioid consumption.
Délai: Postoperative day 1, postoperative day 2, 1 month, and 3 months after surgery.
|
Total opioid consumption during the postoperative period as morphine milligram equivalents
|
Postoperative day 1, postoperative day 2, 1 month, and 3 months after surgery.
|
|
Douleur Neuropathie 4 (DN4) score
Délai: Preoperative assessment, postoperative day 1, postoperative day 2, 1 month, and 3 months after surgery.
|
Neuropathic pain measured using the Douleur Neuropathique 4 (DN4) questionnaire.
Scores range from 0 to 10, with scores greater than or equal to 4 indicating neuropathic pain.
|
Preoperative assessment, postoperative day 1, postoperative day 2, 1 month, and 3 months after surgery.
|
|
Hospitalier Anxiety and depression Scale (HADS) anxiety score
Délai: Preoperative assessment, 1 month, and 3 months after surgery.
|
Anxiety measured using the hospital Anxiety and Depression Scale (HADS-A).
Scores range from 0 to 21, with scores greater than or equal to 11 indicating clinically significant anxiety.
|
Preoperative assessment, 1 month, and 3 months after surgery.
|
|
Hospital Anxiety and Depression Scale (HADS) depression score
Délai: Preoperative assessment, 1 month, and 3 months after surgery
|
Depression measured using the Hospital Anxiety and Depression Scale (HADS-D).
Scores range from 0 to 21, with scores greater than or equal to 11 indicating clinically significant depression.
|
Preoperative assessment, 1 month, and 3 months after surgery
|
|
Brief Pain Inventory (BPI) pain interference score
Délai: 1 month and 3 months after surgery.
|
Pain interference with daily activities measured using the Brief Pain Inventory (BPI) interference subscale
|
1 month and 3 months after surgery.
|
|
Short Form-12 Physical component summary score
Délai: Preoperative assessment, 1 month, and 3 months after surgery.
|
Physical health-related quality of life measured using the Physical Component Summary (PCS) score of the Short Form-12 (SF-12) questionnaire.
|
Preoperative assessment, 1 month, and 3 months after surgery.
|
|
Short form-12 Mental Component Summary score
Délai: Preoperative assessment, 1 month and 3 months after surgery
|
Mental health-related quality of life measured using the Mental Component Summary (MCS) score of the Short Form-12 (SF-12) questionnaire.
|
Preoperative assessment, 1 month and 3 months after surgery
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- RECHMPL 25_0555
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .